LYB001

· Yantai Patronus Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LYB001, covering 2021-11-30 to 2022-11-02. Get the full timeline:

Most recent: Clinical Trial Update: The Phase Ⅱ/Ⅲ Trial of LYB001 [Phase 2, Phase 3]